Abiopharma

Biomerica, Inc. - Egyptian Drug Authority AuthorizesBiomerica’s Complete Screening Test Portfolio

Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio

Innovative Eyewear, Inc. Announces New Reebok® Smart Eyewear for Gym and Indoor Sports

Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)

Guardant Health, Inc. - Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.

Savara Inc. - Savara Announces European Patent Office (EPO) Intends to Grant a Patent for the Liquid Formulation of MOLBREEVI*

Savara Announces European Patent Office (EPO) Intends to Grant a Patent for the Liquid Formulation of MOLBREEVI*

Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.

TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138, following positive readouts from TransCodes Phase 1 trial

DaVita Names New Leaders to Accelerate Care Transformation